← Back to catalogue

Bio2 CLM BG Bioactive Scaffold

FDA 510(k)

Class II (US FDA 510(k))

510(k) K152589

by Bio2 Technologies, Inc.

Identifiers

510(k) Number
K152589 FDA 510(k)
FDA Product Code
MQV FDA 510(k)

Classification

Device Class
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 888.3045 FDA 510(k)
Regulation Number
888.3045 FDA 510(k)
Advisory Committee
Orthopedic FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

The Bio2 CLM BG Bioactive Scaffold is a synthetic, non-collagenous, osteoconductive bone void filler. It is designed to be implanted into skeletal voids in the extremities or pelvis, where the material allows for tissue infiltration between its bioactive glass fibers.

This device is provided as sterile cylinders, blocks, or wedges and complies with the requirements of ASTM F-1538. It received FDA 510(k) clearance under K152589 on January 12, 2016. In vitro testing confirms the formation of a hydroxyapatite layer on the surface of the implant when immersed in simulated body fluid.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Bio2 CLM BG Bioactive Scaffold (K152589) — FDA 510 (k) | Innolitics, Bio2 CLM BG Bioactive Scaffold — FDA 510 (k) K152589 | MedTracker, PDF Bio2 Technologies, Inc. Janet Krevolin, Ph.D. Chief Technical Officer ..., Bio2 CLM BG Bioactive Scaffold - BEUDAMED

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA 510(k) K152589 24 fields · synced Sep 23, 2026